ESC 365 - Prospective RWE - the XANTUS programme.

Open Access

Prospective RWE - the XANTUS programme.

Session: From clinical theory to clinical practice... Phase lll studies of the novel oral anticoagulants (NOACs) to real world evidence (RWE)

Topic: Atrial fibrillation (AF)

Speaker: Professor J. Camm (London, GB)

Sponsored by Bayer AG

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor John Camm

St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)

78 presentations

7 followers

6 more presentations in this session

Opening remarks - From clinical theory to clinical practice... Phase lll studies of the NOACs to RWE.

Speaker: Professor J. Camm (London, GB) Doctor C. Coleman (Storrs, US)

From clinical trial to clinical practice... What questions remain with respect to the NOACs.

Speaker: Doctor M. Patel (Durham, US)

Evaluating the prospective RWE registries... The rules.

Speaker: Associate Professor J. Beyer-Westendorf (Dresden, DE)

Understanding real-world database analyses.

Speaker: Doctor C. Coleman (Storrs, US)

Making sense of the data.

Speaker: Professor J. Camm (London, GB) Doctor C. Coleman (Storrs, US) Associate Professor J. Beyer-Westendorf (Dresden, DE) Doctor M. Patel (Durham, US)

Access the full session

From clinical theory to clinical practice... Phase lll studies of the novel oral anticoagulants (NOACs) to real world evidence (RWE)

Speakers: Professor J. Camm, Professor J. Camm, Doctor C. Coleman, Doctor M. Patel, Associate Professor J. Beyer-Westendorf...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources